Manchester Keith S
CIK 0001244828
Director
Filings
14
Latest Feb 13, 2026
Issuers covered
2
Showing
14 of 14
Page 1
Track record
21 of 21 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 21 | 19% | +1.3% | -1.9% | +32.7% | -21.5% |
| 90 days | 21 | 24% | -13.2% | -11.5% | +7.7% | -33.2% |
| 180 days | 11 | 64% | -5.3% | +8.0% | +19.7% | -40.4% |
| 365 days | 7 | 71% | -1.5% | +8.5% | +8.5% | -27.1% |
Issuers
Companies where Manchester Keith S has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | 10 | Feb 13, 2026 |
| ABUS | Arbutus Biopharma Corp | 4 | Aug 16, 2024 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|